Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1992 May;45(5):385–390. doi: 10.1136/jcp.45.5.385

Detection of high risk human papillomavirus in routine cervical smears: strategy for screening.

C S Herrington 1, M de Angelis 1, M F Evans 1, G Troncone 1, J O McGee 1
PMCID: PMC495297  PMID: 1317884

Abstract

AIM: To develop a methodology for direct detection of high risk human papillomavirus (HPV) infection in routine cervical smears by non-isotopic in situ hybridisation (NISH) which can be compared with cytopathological assessment of the same cells. METHODS: The methodology was established using cultured cells and routine cervical smears hybridised with digoxigenin labelled probes for HPV, 16, 18, 31, and 33. The technique was applied to the analysis of 53 patients from a sexually transmitted disease clinic. RESULTS: The optimal sensitivity achieved for single HPV detection in cultured cells was 1-2 copies of HPV 16 per cell and that for detection of a cocktail of HPV types in routine cervical smears was 2.5-12 copies per cell. Of parallel smears taken from patients with a normal Papinacolau-stained smear 33.3% (24) contained a HPV 16, 18, 31, and 33 signal indicating an occult HPV infection. The prevalence of these HPV types was similar in women in whom a cytopathological diagnosis of wart virus infection was made (64.7%, 17) and in patients with mild dyskaryosis (75%, 12). CONCLUSIONS: The methodology evolved localises HPV sequences directly to epithelial cell nuclei, which can be morphologically assessed by haematoxylin counterstaining. Sample contamination with exogenous viral sequences can be distinguished from true infection. In this study, a HPV signal was not found in morphologically normal epithelial cells. The methods described will permit the detection of HPV sequences in routinely collected cervical smears and the evaluation of the natural history and potential clinical relevance of HPV infection without changes in clinical practice.

Full text

PDF
385

Images in this article

387Image
on p.387
388Image
on p.388
389Image
on p.389

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beyer-Finkler E., Pfister H., Girardi F. Anti-contamination primers to improve specificity of polymerase chain reaction in human papillomavirus screening. Lancet. 1990 May 26;335(8700):1289–1290. doi: 10.1016/0140-6736(90)91365-h. [DOI] [PubMed] [Google Scholar]
  2. Burns J., Graham A. K., Frank C., Fleming K. A., Evans M. F., McGee J. O. Detection of low copy human papilloma virus DNA and mRNA in routine paraffin sections of cervix by non-isotopic in situ hybridisation. J Clin Pathol. 1987 Aug;40(8):858–864. doi: 10.1136/jcp.40.8.858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burns J., Redfern D. R., Esiri M. M., McGee J. O. Human and viral gene detection in routine paraffin embedded tissue by in situ hybridisation with biotinylated probes: viral localisation in herpes encephalitis. J Clin Pathol. 1986 Oct;39(10):1066–1073. doi: 10.1136/jcp.39.10.1066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cooper K., Herrington C. S., Graham A. K., Evans M. F., McGee J. O. In situ human papillomavirus (HPV) genotyping of cervical intraepithelial neoplasia in South African and British patients: evidence for putative HPV integration in vivo. J Clin Pathol. 1991 May;44(5):400–405. doi: 10.1136/jcp.44.5.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cornelissen M. T., van den Tweel J. G., Struyk A. P., Jebbink M. F., Briët M., van der Noordaa J., ter Schegget J. T. Localization of human papillomavirus type 16 DNA using the polymerase chain reaction in the cervix uteri of women with cervical intraepithelial neoplasia. J Gen Virol. 1989 Oct;70(Pt 10):2555–2562. doi: 10.1099/0022-1317-70-10-2555. [DOI] [PubMed] [Google Scholar]
  6. Gergely L., Czeglédy J., Hernády Z. Human papillomavirus frequency in normal cervical tissue. Lancet. 1987 Aug 29;2(8557):513–513. doi: 10.1016/s0140-6736(87)91824-1. [DOI] [PubMed] [Google Scholar]
  7. Gupta J. W., Gupta P. K., Rosenshein N., Shah K. V. Detection of human papillomavirus in cervical smears. A comparison of in situ hybridization, immunocytochemistry and cytopathology. Acta Cytol. 1987 Jul-Aug;31(4):387–396. [PubMed] [Google Scholar]
  8. Herrington C. S., Burns J., Graham A. K., Bhatt B., McGee J. O. Interphase cytogenetics using biotin and digoxigenin labelled probes II: Simultaneous differential detection of human and papilloma virus nucleic acids in individual nuclei. J Clin Pathol. 1989 Jun;42(6):601–606. doi: 10.1136/jcp.42.6.601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Herrington C. S., Burns J., Graham A. K., Evans M., McGee J. O. Interphase cytogenetics using biotin and digoxigenin labelled probes I: relative sensitivity of both reporter molecules for detection of HPV16 in CaSki cells. J Clin Pathol. 1989 Jun;42(6):592–600. doi: 10.1136/jcp.42.6.592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Herrington C. S., Graham A. K., Flannery D. M., Burns J., McGee J. O. Discrimination of closely homologous HPV types by nonisotopic in situ hybridization: definition and derivation of tissue melting temperatures. Histochem J. 1990 Oct;22(10):545–554. doi: 10.1007/BF01005977. [DOI] [PubMed] [Google Scholar]
  11. Lörincz A. T., Temple G. F., Patterson J. A., Jenson A. B., Kurman R. J., Lancaster W. D. Correlation of cellular atypia and human papillomavirus deoxyribonucleic acid sequences in exfoliated cells of the uterine cervix. Obstet Gynecol. 1986 Oct;68(4):508–512. [PubMed] [Google Scholar]
  12. Manos M., Lee K., Greer C., Waldman J., Kiviat N., Holmes K., Wheeler C. Looking for human papillomavirus type 16 by PCR. Lancet. 1990 Mar 24;335(8691):734–734. doi: 10.1016/0140-6736(90)90855-y. [DOI] [PubMed] [Google Scholar]
  13. Matlashewski G. The cell biology of human papillomavirus transformed cells. Anticancer Res. 1989 Sep-Oct;9(5):1447–1456. [PubMed] [Google Scholar]
  14. Melchers W., van den Brule A., Walboomers J., de Bruin M., Burger M., Herbrink P., Meijer C., Lindeman J., Quint W. Increased detection rate of human papillomavirus in cervical scrapes by the polymerase chain reaction as compared to modified FISH and southern-blot analysis. J Med Virol. 1989 Apr;27(4):329–335. doi: 10.1002/jmv.1890270413. [DOI] [PubMed] [Google Scholar]
  15. Mincheva A., Gissmann L., zur Hausen H. Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization. Med Microbiol Immunol. 1987;176(5):245–256. doi: 10.1007/BF00190531. [DOI] [PubMed] [Google Scholar]
  16. Pao C. C., Lai C. H., Wu S. Y., Young K. C., Chang P. L., Soong Y. K. Detection of human papillomaviruses in exfoliated cervicovaginal cells by in situ DNA hybridization analysis. J Clin Microbiol. 1989 Jan;27(1):168–173. doi: 10.1128/jcm.27.1.168-173.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Syrjänen S., Saastamoinen J., Chang F. J., Ji H. X., Syrjänen K. Colposcopy, punch biopsy, in situ DNA hybridization, and the polymerase chain reaction in searching for genital human papillomavirus (HPV) infections in women with normal PAP smears. J Med Virol. 1990 Aug;31(4):259–266. doi: 10.1002/jmv.1890310404. [DOI] [PubMed] [Google Scholar]
  18. Toon P. G., Arrand J. R., Wilson L. P., Sharp D. S. Human papillomavirus infection of the uterine cervix of women without cytological signs of neoplasia. Br Med J (Clin Res Ed) 1986 Nov 15;293(6557):1261–1264. doi: 10.1136/bmj.293.6557.1261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wagner D., Ikenberg H., Boehm N., Gissmann L. Identification of human papillomavirus in cervical swabs by deoxyribonucleic acid in situ hybridization. Obstet Gynecol. 1984 Dec;64(6):767–772. [PubMed] [Google Scholar]
  20. Young L. S., Bevan I. S., Johnson M. A., Blomfield P. I., Bromidge T., Maitland N. J., Woodman C. B. The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection. BMJ. 1989 Jan 7;298(6665):14–18. doi: 10.1136/bmj.298.6665.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. de Villiers E. M. Heterogeneity of the human papillomavirus group. J Virol. 1989 Nov;63(11):4898–4903. doi: 10.1128/jvi.63.11.4898-4903.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. de Villiers E. M., Wagner D., Schneider A., Wesch H., Miklaw H., Wahrendorf J., Papendick U., zur Hausen H. Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet. 1987 Sep 26;2(8561):703–706. doi: 10.1016/s0140-6736(87)91072-5. [DOI] [PubMed] [Google Scholar]
  23. van den Brule A. J., Claas E. C., du Maine M., Melchers W. J., Helmerhorst T., Quint W. G., Lindeman J., Meijer C. J., Walboomers J. M. Use of anticontamination primers in the polymerase chain reaction for the detection of human papilloma virus genotypes in cervical scrapes and biopsies. J Med Virol. 1989 Sep;29(1):20–27. doi: 10.1002/jmv.1890290105. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES